These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36520610)
1. A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects. Dinur E; Goldenberg H; Robinson E; Naggan L; Kozela E; Yirmiya R Cannabis Cannabinoid Res; 2024 Apr; 9(2):561-580. PubMed ID: 36520610 [No Abstract] [Full Text] [Related]
2. Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action. Chaves YC; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM Metab Brain Dis; 2021 Apr; 36(4):639-652. PubMed ID: 33464458 [TBL] [Abstract][Full Text] [Related]
3. Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain. Tito PAL; Bernardino TCS; Bellozi PMQ; da Silva MCM; de Miranda AS; Vieira ÉLM; Moreira FA; Palotás A; de Oliveira ACP; Reis HJ Pharmacol Rep; 2021 Dec; 73(6):1680-1693. PubMed ID: 34218397 [TBL] [Abstract][Full Text] [Related]
4. Prohedonic Effect of Cannabidiol in a Rat Model of Depression. Shoval G; Shbiro L; Hershkovitz L; Hazut N; Zalsman G; Mechoulam R; Weller A Neuropsychobiology; 2016; 73(2):123-9. PubMed ID: 27010632 [TBL] [Abstract][Full Text] [Related]
5. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways. Florensa-Zanuy E; Garro-Martínez E; Adell A; Castro E; Díaz Á; Pazos Á; Mac-Dowell KS; Martín-Hernández D; Pilar-Cuéllar F Biochem Pharmacol; 2021 Mar; 185():114433. PubMed ID: 33513342 [TBL] [Abstract][Full Text] [Related]
6. Shikonin ameliorates depressive- and anxiogenic-like behaviors in rats via the suppression of inflammation in the hippocampus. Shi C; Qi Z; Yang C; Luo S; Huang S; Luo Y Neurosci Lett; 2024 Aug; 837():137893. PubMed ID: 38997082 [TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Sales AJ; Fogaça MV; Sartim AG; Pereira VS; Wegener G; Guimarães FS; Joca SRL Mol Neurobiol; 2019 Feb; 56(2):1070-1081. PubMed ID: 29869197 [TBL] [Abstract][Full Text] [Related]
13. Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice. Liu J; Scott BW; Burnham WM Behav Pharmacol; 2022 Apr; 33(2&3):206-212. PubMed ID: 33883447 [TBL] [Abstract][Full Text] [Related]
15. SuHeXiang Essential Oil Inhalation Produces Antidepressant- and Anxiolytic-Like Effects in Adult Mice. Liang M; Du Y; Li W; Yin X; Yang N; Qie A; Lebaron TW; Zhang J; Chen H; Shi H Biol Pharm Bull; 2018 Jul; 41(7):1040-1048. PubMed ID: 29743387 [TBL] [Abstract][Full Text] [Related]
16. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Fogaça MV; Reis FM; Campos AC; Guimarães FS Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837 [TBL] [Abstract][Full Text] [Related]
17. Atractylenolide III reduces depressive- and anxiogenic-like behaviors in rat depression models. Zhou Y; Huang S; Wu F; Zheng Q; Zhang F; Luo Y; Jian X Neurosci Lett; 2021 Aug; 759():136050. PubMed ID: 34126179 [TBL] [Abstract][Full Text] [Related]
18. Antidepressant effects of Parishin C in chronic social defeat stress-induced depressive mice. Jiang N; Yao C; Zhang Y; Chen Y; Chen F; Luo Y; Choudhary MI; Pan R; Liu X J Ethnopharmacol; 2024 May; 325():117891. PubMed ID: 38331122 [TBL] [Abstract][Full Text] [Related]
19. Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats. Rebai R; Jasmin L; Boudah A Biomed Pharmacother; 2021 Mar; 135():111246. PubMed ID: 33453676 [TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Zanelati TV; Biojone C; Moreira FA; Guimarães FS; Joca SR Br J Pharmacol; 2010 Jan; 159(1):122-8. PubMed ID: 20002102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]